Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)
Furst, Daniel E, Schiff, Michael H, Fleischmann, Roy M, Strand, Vibeke, Birbara, Charles A, Compagnone, Daniele, Fischkoff, Steven A, Chartash, Elliot K
Published in Journal of rheumatology (01.12.2003)
Get more information
Published in Journal of rheumatology (01.12.2003)
Journal Article
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Edwards, Christopher J, Blanco, Francisco J, Crowley, Jeffrey, Birbara, Charles A, Jaworski, Janusz, Aelion, Jacob, Stevens, Randall M, Vessey, Adele, Zhan, Xiaojiang, Bird, Paul
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy
Furst, Daniel E, Kavanaugh, Arthur, Florentinus, Stefan, Kupper, Hartmut, Karunaratne, Mahinda, Birbara, Charles A
Published in Rheumatology (Oxford, England) (01.12.2015)
Published in Rheumatology (Oxford, England) (01.12.2015)
Get full text
Journal Article
Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis
Gottlieb, Alice B., Papp, Kim A., Birbara, Charles A., Shuler, Catherine L., Burge, Russel, Erickson, Janelle, Kerr, Lisa, Mease, Philip J.
Published in Journal of the American Academy of Dermatology (01.09.2018)
Published in Journal of the American Academy of Dermatology (01.09.2018)
Get full text
Journal Article
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial
Doyle, Mittie K, Rahman, Mahboob U, Frederick, Bart, Birbara, Charles A, de Vries, Dick, Toedter, Gary, Wu, Xiaoying, Chen, Dion, Ranganath, Veena K, Westerman, Mark E, Furst, Daniel E
Published in Rheumatology (Oxford, England) (01.07.2013)
Published in Rheumatology (Oxford, England) (01.07.2013)
Get full text
Journal Article
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies
Gladman, Dafna D, Kavanaugh, Arthur, Gómez-Reino, Juan J, Wollenhaupt, Jürgen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J
Published in Rheumatic & musculoskeletal diseases open (01.06.2018)
Published in Rheumatic & musculoskeletal diseases open (01.06.2018)
Get full text
Journal Article
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial
Birbara, Charles A, Puopolo, Anthony D, Munoz, David R, Sheldon, Eric A, Mangione, Antoinette, Bohidar, Norman R, Geba, Gregory P
Published in The journal of pain (01.08.2003)
Published in The journal of pain (01.08.2003)
Get full text
Journal Article
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
Weinblatt, Michael E., Keystone, Edward C., Furst, Daniel E., Moreland, Larry W., Weisman, Michael H., Birbara, Charles A., Teoh, Leah A., Fischkoff, Steven A., Chartash, Elliot K.
Published in Arthritis and rheumatism (01.01.2003)
Published in Arthritis and rheumatism (01.01.2003)
Get full text
Journal Article
164 Long-term (four year) 28-joint count disease activity score (C-reactive protein) remission and improvements in skin disease with apremilast: phase III results from PALACE3
Edwards, Christopher, Blanco, Francisco J, Crowley, Jeffrey, Paris, Maria, Delev, Nikolay, Teng, Lichen, Birbara, Charles A
Published in Rheumatology (Oxford, England) (01.04.2018)
Published in Rheumatology (Oxford, England) (01.04.2018)
Get full text
Journal Article
068. 28-JOINT DISEASE ACTIVITY SCORE REMISSION AND IMPROVEMENTS IN SKIN DISEASE OVER 3 YEARS OF TREATMENT WITH APREMILAST: RESULTS FROM THE PALACE 3 STUDY IN DISEASE-MODIFYING ANTI-RHEUMATIC DRUG/BIOLOGIC-EXPERIENCED ACTIVE PSORIATIC ARTHRITIS PATIENTS
Edwards, Christopher J., Blanco, Francisco J., Crowley, Jeffrey, McIlraith, Melissa, Shah, Kamal, Teng, Lichen, Birbara, Charles A.
Published in Rheumatology (Oxford, England) (01.04.2017)
Published in Rheumatology (Oxford, England) (01.04.2017)
Get full text
Journal Article
166 Long-term (156-week) improvements in dactylitis and enthesitis with apremilast inpsoriatic arthritis subjects: analysis of a large, pooled PALACE 1-3 database
Gladman, Dafna D, Kavanaugh, Arthur, Gomez-Reino, Juan J, Wollenhaupt, Jurgen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, Hu, Angela, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J
Published in Rheumatology (Oxford, England) (01.04.2018)
Published in Rheumatology (Oxford, England) (01.04.2018)
Get full text
Journal Article
214. Efficacy of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis and Current Skin Involvement: Results of Palace 3, a Phase 3, Randomized, Controlled Trial
Edwards, Christopher J., Blanco, Francisco J., Crowley, Jeffrey, Hu, ChiaChi, Stevens, Randall M., Birbara, Charles A.
Published in Rheumatology (Oxford, England) (01.04.2014)
Published in Rheumatology (Oxford, England) (01.04.2014)
Get full text
Journal Article
212. Long-Term 52-Week Results of Palace 3, A Phase 3, Randomized, Controlled Trial of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis and Current Skin Involvement
Edwards, Christopher J., Blanco, Francisco J., Crowley, Jeffrey, Hu, ChiaChi, Stevens, Randall M., Birbara, Charles A.
Published in Rheumatology (Oxford, England) (01.04.2014)
Published in Rheumatology (Oxford, England) (01.04.2014)
Get full text
Journal Article
O03Apremilast, an Oral Phosphodiesterase-4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials
Gladman, Dafna D, Kavanaugh, Arthur, Adebajo, Adewale O, Gomez-Reino, Juan J, Wollenhaupt, Juergen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, McIlraith, Melissa, Hu, ChiaChi, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J
Published in Rheumatology (Oxford, England) (01.04.2016)
Published in Rheumatology (Oxford, England) (01.04.2016)
Get full text
Journal Article